The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis
- 1 November 2001
- journal article
- research article
- Published by Elsevier BV in Current Biology
- Vol. 11 (22), 1739-1748
- https://doi.org/10.1016/s0960-9822(01)00536-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Analysis of the transcriptional program induced by Raf in epithelial cellsGenes & Development, 2001
- The PEA3 Subfamily of Ets Transcription Factors Synergizes with β-Catenin–LEF-1 To Activate Matrilysin Transcription in Intestinal TumorsMolecular and Cellular Biology, 2001
- The PEA3 Ets Transcription Factor Comprises Multiple Domains That Regulate Transactivation and DNA BindingPublished by Elsevier BV ,2001
- PEA3 Is Up-regulated in Response to Wnt1 and Activates the Expression of Cyclooxygenase-2Published by Elsevier BV ,2001
- HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancerOncogene, 1997
- Genomic Organization of the Human ERM (ETV5) Gene, a PEA3 Group Member of ETS Transcription FactorsGenomics, 1996
- Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex AssemblyScience, 1996
- Involvement of Ets‐related proteins in hormone‐independent mammary cell‐specific gene expressionEuropean Journal of Biochemistry, 1994
- Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells.Genes & Development, 1992
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987